Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients

Summary:

We noted a significant increase of interleukin-8 (IL-8), LBP and CRP mirroring the pattern of mucosal barrier injury as measured by gut integrity (lactulose/rhamnose ratio), daily mucositis score (DMS) and serum citrulline concentrations of 32 haematopoietic stem cell transplant (HSCT) recipients following intensive myeloablative therapy. Concentrations of IL-8, LBP and CRP were already significantly elevated before the onset of fever or bacteraemia due to oral viridans streptococci (OVS) in the first week after transplant during profound neutropenia. These markers reached their peak when citrulline concentrations reached their nadir, the highest scores of DMS were attained and when there was significantly decreased gut integrity. This suggests that the degree of mucosal barrier injury rather than bacteraemia due to OVS determines the intensity of the inflammatory response.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Blijlevens NM, Donnelly JP, de Pauw BE . Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant 2000; 25: 1269–1278.

    Article  CAS  Google Scholar 

  2. Hill GR, Ferrara JL . The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 2000; 95: 2754–2759.

    CAS  Google Scholar 

  3. van’t Land B, Blijlevens NM, Marteijn J et al. Role of curcumin and the inhibition of NF-kappaB in the onset of chemotherapy-induced mucosal barrier injury. Leukemia 2004; 18: 276–284.

    Article  Google Scholar 

  4. Xun CQ, Thompson JS, Jennings CD et al. Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice. Blood 1994; 83: 2360–2367.

    CAS  Google Scholar 

  5. Otte JM, Podolsky DK . Functional modulation of enterocytes by Gram-positive and Gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol 2004; 286: G613–G626.

    Article  CAS  Google Scholar 

  6. Keefe DM, Brealey J, Goland GJ, Cummins AG . Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 2000; 47: 632–637.

    Article  CAS  Google Scholar 

  7. Ruescher TJ, Sodeifi A, Scrivani SJ et al. The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer 1998; 82: 2275–2281.

    Article  CAS  Google Scholar 

  8. Schaap N, Schattenberg A, Bar B et al. Outcome of transplantation for standard-risk leukaemia with grafts depleted of lymphocytes after conditioning with an intensified regimen. Br J Haematol 1997; 98: 750–759.

    Article  CAS  Google Scholar 

  9. Blijlevens NM, van’t Land B, Donnelly JP et al. Measuring mucosal damage induced by cytotoxic therapy. Support Care Cancer 2004; 12: 227–233.

    Article  CAS  Google Scholar 

  10. Donnelly JP, Dompeling EC, Meis JF, de Pauw BE . Bacteremia due to oral viridans streptococci in neutropenic patients with cancer: cytostatics are a more important risk factor than antibacterial prophylaxis. Clin Infect Dis 1995; 20: 469–470.

    Article  CAS  Google Scholar 

  11. Lutgens LC, Blijlevens NM, Deutz NE et al. Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests. Cancer 2005; 103: 191–199.

    Article  Google Scholar 

  12. Blijlevens NM, Lutgens LC, Schattenberg AV, Donnelly JP . Citrulline: a potentially simple quantitative marker of intestinal epithelial damage following myeloablative therapy. Bone Marrow Transplant 2004; 34: 193–196.

    Article  CAS  Google Scholar 

  13. Donnelly JP, Muus P, Schattenberg A et al. A scheme for daily monitoring of oral mucositis in allogeneic BMT recipients. Bone Marrow Transplant 1992; 9: 409–413.

    CAS  Google Scholar 

  14. Oude Nijhuis CS, Vellenga E, Daenen SM et al. Endothelial cells are main producers of interleukin 8 through Toll-like receptor 2 and 4 signaling during bacterial infection in leukopenic cancer patients. Clin Diagn Lab Immunol 2003; 10: 558–563.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Levy O, Teixeira-Pinto A, White MLD et al. Endotoxemia and elevation of lipopolysaccharide-binding protein after hematopoietic stem cell transplantation. Pediatr Infect Dis J 2003; 22: 978–981.

    Article  Google Scholar 

  16. Tsuji E, Hiki N, Nomura S et al. Simultaneous onset of acute inflammatory response, sepsis-like symptoms and intestinal mucosal injury after cancer chemotherapy. Int J Cancer 2003; 107: 303–308.

    Article  CAS  Google Scholar 

  17. Ellis M . Preventing microbial translocation in haematological malignancy. Br J Haematol 2004; 125: 282–293.

    Article  Google Scholar 

  18. Frere P, Hermanne JP, Debouge MH et al. Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures. Bone Marrow Transplant 2004; 33: 745–749.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank M Balvers for providing technical assistance and Eveline de Bont for determining IL-8 and LBP.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N M A Blijlevens.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blijlevens, N., Donnelly, J. & DePauw, B. Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients. Bone Marrow Transplant 36, 703–707 (2005). https://doi.org/10.1038/sj.bmt.1705118

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705118

Keywords

This article is cited by

Search

Quick links